Experienced in Sideroblastic Anemia

Dr. Samith T. Kochuparambil

Hematology Oncology | Oncology | Hematology
Novacare Outpatient Rehabilitation East, Inc.
480 Hwy 96 E, Suite 120, 
Vadnais Heights, MN 
Accepting New Patients
Offers Telehealth
Experienced in Sideroblastic Anemia
Novacare Outpatient Rehabilitation East, Inc.
480 Hwy 96 E, Suite 120, 
Vadnais Heights, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Samith Kochuparambil is a Hematologist Oncology specialist and an Oncologist in Vadnais Heights, Minnesota. Dr. Kochuparambil is rated as an Experienced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Multiple Myeloma, Neuroendocrine Tumor, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration. Dr. Kochuparambil is currently accepting new patients.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Hematology
Licenses
Internal Medicine in MN
Hospital Affiliations
Abbott Northwestern Hospital
Languages Spoken
English
Hindi
Malayalam
Tamil
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

NOVACARE OUTPATIENT REHABILITATION EAST, INC.
480 Hwy 96 E, Suite 120, Vadnais Heights, MN 55127
Other Locations
MINNESOTA ONCOLOGY HEMATOLOGY PA
910 E 26th St, Suite 100 200, Minneapolis, MN 55404

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Drug
Study Drug: Avelumab
Study Phase: Phase 3
A Phase Ib Open-Label, Dose-Finding Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination With M9241(NHS-IL12) in Subjects With Locally Advanced, Unresectable, or Metastatic Solid Tumors
A Phase Ib Open-Label, Dose-Finding Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination With M9241(NHS-IL12) in Subjects With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Enrollment Status: Terminated
Publish Date: September 20, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy
A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Combination product
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

15 Total Publications

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.
Journal: Nature communications
Published: February 28, 2025
Similar Doctors
Advanced in Sideroblastic Anemia
Dr. Mark R. Menge
Hematology Oncology | Hematology | Oncology
Advanced in Sideroblastic Anemia
Dr. Mark R. Menge
Hematology Oncology | Hematology | Oncology

Park Nicollet Clinic

15800 95th Ave N, 
Maple Grove, MN 
 (19.8 miles away)
952-993-1440
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Menge is a Hematologist Oncology specialist and a Hematologist in Maple Grove, Minnesota. Dr. Menge is rated as an Advanced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Familial Prostate Cancer, Small Cell Lung Cancer (SCLC), Familial Pancreatic Cancer, Lung Cancer, and Bone Marrow Aspiration. Dr. Menge is currently accepting new patients.

Advanced in Sideroblastic Anemia
Dr. Joseph I. Levine
Hematology Oncology | Hematology | Oncology
Advanced in Sideroblastic Anemia
Dr. Joseph I. Levine
Hematology Oncology | Hematology | Oncology

North Memorial Health Care

3300 Oakdale Ave N, 
Robbinsdale, MN 
 (12.6 miles away)
763-581-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Levine is a Hematologist Oncology specialist and a Hematologist in Robbinsdale, Minnesota. Dr. Levine is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Lynch Syndrome. Dr. Levine is currently accepting new patients.

Advanced in Sideroblastic Anemia
Dr. Rajini K. Malisetti
Hematology Oncology | Oncology
Advanced in Sideroblastic Anemia
Dr. Rajini K. Malisetti
Hematology Oncology | Oncology

Minnesota Oncology Hematology PA

910 E 26th St, Suite 100 200, 
Minneapolis, MN 
 (12.2 miles away)
612-884-6300
Languages Spoken:
English, Hindi, Telugu
See accepted insurances
Accepting New Patients

Rajini Malisetti is a Hematologist Oncology specialist and an Oncologist in Minneapolis, Minnesota. Dr. Malisetti is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma. Dr. Malisetti is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kochuparambil's expertise for a condition
ConditionClose
    View All 47 Advanced Conditions
    View All 150 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile